7 Results for "

histone marks

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "histone marks" in MCE Product Catalog:

Cat. No.: HY-117491
CAS No.: 1660117-38-3
Purity:  99.52%
Research Areas:  

Cancer

BRD4 Inhibitor-10 is a potent BRD4-BD1 inhibitor with an IC50 of 8 nM. BRD4 Inhibitor-10 interferes with the recognition of acetylated histone marks by the BRD4 bromodomain through inhibiting the interaction between BRD4-BD1 and tetra-acetylated histone H4 peptide. BRD4 Inhibitor-10 is used for research on BRD4-mediated epigenetic regulation and cancer .
loading...
    loading...
Cat. No.: HY-P2254
Research Areas:  

Cancer

H3K27(Me3) (15-34), a histone peptide, is a repressive chromatin mark derived from human histone. Polycomb Repressive Complex 2 (PRC2) is a multiprotein complex that catalyzes the methylation of H3K27(Me) .
loading...
    loading...
Cat. No.: HY-157140
CAS No.: 1644442-22-7
Research Areas:  

Others

HibK is is a new type of histone mark that is widely distributed in histone proteins. HibK as a useful tool can be used for probing post-translational modification by site-specifically incorporate HibK into proteins .
loading...
    loading...
Cat. No.: HY-P2253
Target:  

Histone Demethylase

Research Areas:  

Cancer

H3K27(Me2) (15-34), a histone peptide, is a repressive chromatin mark derived from human histone. Polycomb Repressive Complex 2 (PRC2) is a multiprotein complex that catalyzes the methylation of H3K27(Me) .
loading...
    loading...
Cat. No.: HY-121009
CAS No.: 748777-47-1
Research Areas:  

Cancer

CCT077791 is a PCAF (IC50: 7.3 μM (FlashPlate); 2.2 μM (Filter assay)) and p300 histone acetyltransferase inhibitor. CCT077791 reduces total acetylation of histones H3 and H4, levels of specific acetylated lysine marks, and acetylation of α-tubulin. CCT077791 can be used in the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-121511
CAS No.: 2101206-36-2
Research Areas:  

Cancer

EML631 is a SPIN1 inhibitor with a Kd of 3-7 μM. EML631 interacts with the second Tudor domain of SPIN1 and blocks its ability to read the H3K4me3 histone mark. EML631 inhibits the coactivator activity of SPIN1 in the Wnt signaling pathway and reduces the activity of Wnt response reporter genes. EML631 can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-183058
CAS No.: 2140164-84-5
Research Areas:  

Cancer

EZM8266 is an orally active and selective G9a (EHMT2) histone methyltransferase inhibitor with a human EHMT2 IC50 of 1 pM. EZM8266 reduces repressive H3K9me2 marks at immune-stimulatory gene and endogenous retroviral element promoters. EZM8266 reduces colony formation, migration, and invasion of cancer cells. EZM8266 enhances IFN-γ response, increases MHC class I expression, and enhances CXCL10-mediated T cell recruitment in cancer cells. EZM8266 can be used for the research of hepatocellular carcinoma .
loading...
    loading...